Ongoing research aims to improve the efficacy of EGFR-targeted therapies and overcome resistance mechanisms. Combination therapies that target multiple pathways, development of next-generation inhibitors, and personalized medicine approaches based on genetic profiling are some of the promising strategies. Furthermore, understanding the role of EGFR in the tumor microenvironment and its interaction with other oncogenic pathways will provide deeper insights into cancer biology and treatment.
